AstraZeneca’s Imfinzi in combination with Imjudo plus platinum-based chemotherapy has been approved for treatment of patients with Stage IV non-small cell lung cancer (NSCLC). The approval has been made by the Food…
Tag: New Lung Cancer Treatment
FDA Grants Approval to Trastuzumab Deruxtecan for HER2 Lung Cancer
Lung cancer patients now have another treatment option. For those tumors carrying HER2 mutations, can now be treated with trastuzumab deruxtecan. This drug is already approved for use in HER2-positive breast cancer…
Lung Cancer Treatment Side Effects Prevented with Genetic Discovery
Lung cancer is one of the deadliest forms of cancers prevalent globally. Immunotherapy has emerged as one of the most effective ways to control this disease. But, it causes several side effects…
Plant Compound Berberine May Help Fight Lung Cancer
Lung cancer is the leading cause of cancer related deaths among men and women and the scientific community continues to make efforts to find new ways for lung cancer treatment. In a…
FDA Approves FoundationOne CDx in Non-Small Cell Lung Cancer
U.S. Food and Drug Administration (FDA) has approved the FoundationOne CDx as a companion diagnostic to guide treatment selection for patients with non-small cell lung cancer. This approval applies to the use…
Study Finds New Possibilities for Lung Cancer Treatment in ‘Never Smokers’
Smoking is the well-known reason for causing lung cancer among a significant amount of people. But, there are also those lung cancer patients who have never smoked in their life but still…
Robotic Surgery for Lung Cancer: What You Need to Know
In today’s article, we are taking a close look at robotic surgery for lung cancer. Robotic lung surgery was introduced back in 2002 and the technique is called as RATS which is…
Takeda’s Exkivity Approved by FDA for Rare form of Lung Cancer
Takeda Pharmaceutical Co. Ltd. becomes the first one to get FDA approval for an oral drug targeted against rare form of non-small cell lung cancer. FDA has approved Exkivity (mobocertinib) for treatment…